Inofert HP Dietary Supplement for Women with Polycystic Ovary Syndrome 20 SachetsInofert HP 20 SachetsDietary Supplement with Myo-Inositol, Alpha-Lactalbumin & Folic Acid for Women with Polycystic Ovary Syndrome
Polycystic Ovary Syndrome (PCOS) is one of the most common problems of young women. It has a complex nosological entity with a genetic background and significant interaction between the genetic substrate & the effect of the environment. It is follicles that contain eggs, but due to hormonal disorders, these follicles have not developed and show stagnation in their evolutionary course. Polycystic ovaries are found in about 20 – 30% of women.
Inofert HP® is the natural solution for the therapeutic management of all symptoms of Polycystic Ovary Syndrome (PCOS). Inofert HP® thanks to its targeted composition & its action documented by multiple clinical studies, improves the metabolic & hormonal profile of women with PCOS, effectively regulating the function of the ovaries, even those that had not responded to previous treatment with myo-inositol.
Main ingredients Inofert HP®
MYO-INOSITOLMyo-inositol is a vitamin-like factor of the B vitamin complex and its administration to women with PCOS:
- normalizes the menstrual cycle,
- restores hormonal balance and ovulation,
- improves fertility,
- improves the metabolism of sugars and lipids
- reduces acne and hirsutism
ALPHA-LACTALBUMINAlpha-lactalbumin is a protein with multi-faceted action (immuno-modulating, anti-inflammatory, prebiotic & mucoprotective).
restores the microbial flora of the intestine, improving the normal absorption of nutrients (myo-inositol & other nutrients).
reduces inflammation and, consequently, hyperandrogenism in Polycystic Ovary Syndrome (PCOS).
FOLIC ACIDFolic acid participates in the production of new cells, in hematopoiesis and contributes to the smooth development of the embryo's neural tube. In the daily dosage of Inofert HP® it is the recommended daily dose for women of reproductive age who wish to conceive, reducing the risk of adverse outcomes in pregnancy.
16 
